Prof. Monique Robool discusses her motivation for joining PIONEER and why she is passionate about both federated and central data sharing models
Dr. Azieh Agozar explains how the PIONEER studyahton was the first to be held outside OHDSI and the lesson we learned from this for future studies within the project
Prof. Dr. Maria Ribal explains the importance of disseminating PIONEER’s objectives and outcomes to all stakeholders and discusses the importane of RWE
Dr. Susan Evans Axelsson expalins her role as EFPIA Lead for PIONEER and the importance of supporting partners to contribute data
Dr. August Sigle tells us why the University Clinic Freiburg choose to join PIONEER and why this project is important for urologists and patients
Prof. Dr. Mauro Gacci & Dr. Rossella Nicoletti University of Florence discuss their motivation for joining PIONEER and why they choose to share their data.
Prof. Dr. Alberto Briganti discusses the important of core outcome sets amd patient reported outcome measures to the research within PIONEER.
Prof. Dr. James N’Dow highlights the changes happening within evidence generation for clinical practice guidelines development.
Prof. Dr. Maria Ribal discusses the evidence gaps in healthcare and how Big Data and Real-World Evidence can help us address these
Prof. Dr. Philip Cornford discusses the benefits of using the PIONEER approach for answering prostate cancer research questions.
Prof. Dr. Nicolas Mottet discusses the challanges of defining the prostate cancer research questions for the analytic approach used in PIONEER
PIONEER General Assembly Meeting May 2022 catch up on all our progress over th epast 12 months
Memebrs of WP2 (Disease Understanding & Outcomes) explain the PIONEER Core Outcome Sets and why they are important
Interested in PIONEER watch our short animated video to find out more about the project and our objectives.
Monique Roobol, Erasmus MC, explains why she believes contributing data to PIONEER is of critical importance.
James N’Dow Academic lead for PIONEER reflects on the first twelve months of the project.
Alex Asiimwe EFPIA lead for PIONEER discusses the unique public-private aspects of BD4BO.
Zsuzsanna Devecseri EFPIA co-lead for PIONEER discusses prostate cancer outcomes.
Mieke Van Hemelrijck WP2 explains the importance of define core outcome sets for prostate cancer.
Anders Bjartell WP3 data sources and access discusses the PIONEER data models.
Thomas Abbott EFPIA co-lead for PIONEER discusses data sources and access to data.
Billy Franks WP5 explains the importance of data analysis plans for PIONEER’s research questions.
Denis Horgan explains the importance of actively engaging policy makers in PIONEER.
Maria Ribal WP7 discusses how effective dissemination is key to PIONEER’s long-term success.
Louise Fullwood WP8 explains the legal and ethical issues around data privacy within PIONEER.
PIONEER research associates from both academic & industry discuss their experience of working together.
The patient perspective – Gary Hooker
The patient perspective – Ken Mastris
The patient perspective – Erik Briers